Kiniksa Pharmaceuticals, Ltd. reported raising $5.95 Million in an initial SEC Form D filing, from an offering of $5.95 Million
PUBLIC · KNSAApr 04, 2019 Amount Raised
$5.95 Million
$5.95 Million sold, per SEC Form D (first sale Apr 4, 2019)
LexingtonBiotechnologyHealthcarePharmaceuticalBiopharmaWho to call at Kiniksa Pharmaceuticals, Ltd., and when
A new round usually means Kiniksa Pharmaceuticals, Ltd. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Kiniksa Pharmaceuticals, Ltd. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Kiniksa Pharmaceuticals, Ltd., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Kiniksa Pharmaceuticals, Ltd.. With Fundz connected, it knows.
Watch Fundz in Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★ 4.8/5 on G2
Company
Kiniksa Pharmaceuticals, Ltd.
Location
100 Hayden Avenue
Lexington, Massachusetts, United States
About
Kiniksa Pharmaceuticals is developing therapies for inflammatory and autoimmune conditions.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Kiniksa Pharmaceuticals, Ltd. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Kiniksa Pharmaceuticals, Ltd. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.
